China Nepstar Chain Drugstore Ltd (NPD) 2.55 $NPD China

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Nepstar Chain Drugstore Ltd (NPD) 2.55 $NPD

China Nepstar Chain Drugstore Ltd. Announces Completion of Merger
PR Newswire - Wed Aug 03, 3:30PM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today the completion of its merger (the "merger" with Neptunus Global Limited ("Merger Sub" , a wholly-owned subsidiary of China Neptunus Drugstore Holding Ltd. ("Parent" , pursuant to the agreement and plan of merger (the "merger agreement" dated March 16, 2016 by and among Parent, Merger Sub and the Company. As a result of the merger, the Company ceased to be a publicly traded company and became a wholly-owned subsidiary of Parent.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger
PR Newswire - Fri Jul 29, 5:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that, at an extraordinary general meeting of the Company's shareholders held on July 29, 2016, the Company's shareholders voted in favor of, and passed a special resolution to approve, among others, the proposal to authorize and approve (i) the previously announced agreement and plan of merger (the "merger agreement" dated March 16, 2016 by and among China Neptunus Drugstore Holding Ltd. ("Parent" , Neptunus Global Limited ("Merger Sub" and the Company, pursuant to which Merger Sub will be merged with and into the Company with the Company continuing as the surviving company as a wholly-owned subsidiary of Parent after the merger (the "merger" , (ii) the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached to the merger agreement (the "plan of merger" , and (iii) any and all transactions contemplated by the merger agreement, including the merger.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Extraordinary General Meeting of Shareholders
PR Newswire - Wed Jun 22, 5:30AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has called an extraordinary general meeting of shareholders (the "EGM" , to be held at 10:00 a.m. Beijing Time on July 29, 2016, at the Company's office at 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, Shenzhen, Guangdong Province, 518057, People's Republic of China, to consider and vote on, among other things, the proposal to authorize and approve the previously announced agreement and plan of merger (the "Merger Agreement" dated March 16, 2016, by and among China Neptunus Drugstore Holding Ltd. ("Parent" , Neptunus Global Limited ("Merger Sub" and the Company, the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached as Appendix I to the Merger Agreement (the "Plan of Merger" and the transactions contemplated thereby (including the Merger, as defined below).
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 31, 3:52AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2016.
NPD: 2.55 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore First Quarter 2016 Earnings Conference Call on Tuesday, May 31, 2016
ACCESSWIRE - Fri May 27, 3:10PM CDT
SHENZHEN, CHINA / ACCESSWIRE / May 27, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the first quarter 2016, to be held Tuesday, May 31, 2016 at 8:00 AM Eastern Time.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore to Report First Quarter 2016 Financial Results on May 31, 2016
PR Newswire - Wed May 25, 3:14AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the first quarter of 2016 on May 31, 2016 before the market opens.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Filed 2015 Annual Report on Form 20-F
PR Newswire - Wed Apr 27, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced the Company filed its annual report on Form 20-F for the year ended December 31, 2015 with the Securities and Exchange Commission on April 26, 2016. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2015, free of charge, to its shareholders and ADS holders upon request.
NPD: 2.55 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore Fourth Quarter and Fiscal Year 2015 Earnings Conference Call on Tuesday, March 29, 2016
ACCESSWIRE - Mon Mar 28, 3:07PM CDT
SHENZHEN, CHINA / ACCESSWIRE / March 28, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the fourth quarter and fiscal year 2015, to be held Tuesday, March 29, 2016 at 8:00 AM Eastern Time.
NPD: 2.55 (+0.01)

These China Focused Small Cap Stocks Have Interesting Growth Stories
ACCESSWIRE - Tue Nov 17, 7:00AM CST
MIAMI, FL / ACCESSWIRE / November 17, 2015 / China has been one of the most down-beat countries over the last few quarters with equities losing value across board. However, not everything about China is all bad, especially when looking at some of the most promising small cap plays traded in the US.
NPD: 2.55 (+0.01), CJJD: 1.95 (+0.03), LITB: 3.22 (-0.14)

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results
PR Newswire - Wed Sep 02, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2015.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore to Report Second Quarter 2015 Financial Results on September 2, 2015
PR Newswire - Tue Aug 11, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the second quarter of 2015 on September 2, 2015 before the market opens.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Special Committee Retains Financial Advisor and Legal Counsel
PR Newswire - Thu Aug 06, 3:43AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the special committee (the "Special Committee" of the Company's board of directors has retained Houlihan Lokey (China) Limited as its financial advisor and Shearman & Sterling LLP as its United States legal counsel in connection with its review and evaluation of the previously announced preliminary non-binding "going private" proposal letter that the Company's board of directors received on July 6, 2015.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider "Going Private" Proposal
PR Newswire - Fri Jul 17, 7:38PM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors (the "Board" has formed a special committee consisting of three independent directors (the "Special Committee" , Mr. Barry J. Buttifant, Mr. Alistair Eric MacCallum Laband and Mr. Alan Au, to consider the previously announced preliminary non-binding "going private" proposal letter that the Board received on July 6, 2015. Mr. Barry J. Buttifant will chair the Special Committee. The Special Committee intends to retain independent legal and financial advisors to assist it in this process.
NPD: 2.55 (+0.01)

China Stock Roundup: Mindray Medical to Buy Remaining Stake in Dragonbio, Noah Holdings Announces Buyback - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Jul 09, 3:36PM CDT
Markets had a dismal week, despite a series of measures taken by the government to boost markets.
NPD: 2.55 (+0.01), SOL: 1.14 (-0.03), NOAH: 26.28 (+0.10), PBR: 9.58 (+0.36), CEO: 123.29 (+2.65), SNP: 73.37 (+2.03), TSL: 10.49 (unch), MR: 27.94 (+0.07), PTR: 67.55 (+1.68), ZNH: 29.74 (+0.33), BABA: 99.25 (+1.83)

China Nepstar Chain Drugstore receives going private proposal at USD1.30 per share or USD2.60 per ADS in cash
M2 - Tue Jul 07, 3:38AM CDT
Retail drugstore China Nepstar Chain Drugstore (NYSE:NPD) said on Monday that its board of directors has received a preliminary non-binding proposal letter for the acquisition of all of the outstanding ordinary shares at USD1.30 per share and the American Depositary Shares at USD2.60 per ADS in cash in a going private transaction.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal
PR Newswire - Mon Jul 06, 2:49AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has received a preliminary non-binding proposal letter, dated July 6, 2015, from Simin Zhang, chairman of the board of directors of the Company, and China Neptunus Drugstore Holding Ltd., an investment vehicle wholly owned by Mr. Zhang("Neptunus Holding", and collectively with Mr. Zhang, the "Buyer Parties" , pursuant to which the Buyer Parties propose to acquire all of the outstanding ordinary shares (the "Shares" and the American Depositary Shares ("ADSs", each representing two Shares) of the Company, in both cases, that are not already beneficially owned by the Buyer Parties and their affiliates at a price of US$1.30 per Share or US$2.60 per ADS, as the case may be, in cash, in a going private transaction(the "Acquisition" , subject to certain conditions.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Up 9.5%, Shares Break Through Resistance (NPD)
Comtex SmarTrend(R) - Mon Jun 08, 11:47AM CDT
China Nepstar Chain Drugstore (NYSE:NPD) is one of today's best performing low-priced stocks, up 9.5% to $2.77 on 1.3x average daily volume. Thus far today, China Nepstar Chain Drugstore has traded 297,000 shares, vs. average volume of 230,000 shares per day. The stock has outperformed the Dow (9.5% to the Dow's -0.2%) and outperformed the S&P 500 (9.5% to the S&P's -0.3%) during today's trading.
NPD: 2.55 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Nuclear Discussions: Iran and Europe Set for Talks

Updated Category News Views 363

Overview of Upcoming Nuclear Talks The landscape surrounding nuclear negotiations is an intricate one, especially with regard to Iran and its interactions with European nations. The next pivotal meeting is anticipated in Geneva, as confirmed by Iran's Deputy Foreign Minister Kazem Gharibabadi. This gathering is significant as it marks another step in navigating the...

Continue Reading
Upcoming Marina Development Project Set to Transform Bay Area

Updated Category News Views 181

Exciting Developments in Marina Construction Kenwood Investment and Suntex Marinas have unveiled plans for a significant upgrade in the Bay Area with a new 168-slip marina project. This venture at Clipper Cove marks a pivotal advancement in recreational facilities for the community. Joint Venture Agreement and Next Steps The two companies have formed a joint venture to...

Continue Reading
Innovative Therapy LYT-200 Showcased for AML Treatment Progress

Updated Category News Views 108

Groundbreaking Data on LYT-200 for AML/MDS Treatment BOSTON--PureTech Health plc (Nasdaq: PRTC) is at the forefront of cancer treatment innovations with their dedication to enhancing patient outcomes through advanced biotherapeutics. Recently, the company presented promising data on LYT-200, their anti-galectin-9 monoclonal antibody, during a significant annual meeting in...

Continue Reading
Battery Show Asia 2026: A Catalyst for Energy Innovations

Updated Category News Views 217

The Battery Show Asia 2026: A Grand Return of Innovation The Battery Show Asia (TBSA) 2026 promises an exciting comeback at AsiaWorld-Expo. Following the success of the inaugural edition, TBSA 2026 is expected to attract a diverse range of attendees. Building on the foundation laid in previous years, this event will delve deeper into the ever-evolving landscape of energy...

Continue Reading
Centuri Holdings Elevates Chris Brown to CEO Role

Updated Category News Views 244

Centuri Holdings Welcomes Chris Brown as New CEO Centuri Holdings, Inc. (NYSE: CTRI), a prominent utility infrastructure services provider, has announced an important leadership change. The company's Board of Directors has appointed Christian "Chris" Brown as the new President and Chief Executive Officer. This transition is set to take effect on an upcoming date, marking...

Continue Reading